India’s medical devices get boost from domestic manufacturing push | Healthcare Asia Magazine
, India
192 views

India’s medical devices get boost from domestic manufacturing push

The country’s new national medical devices policy is expected to reduce import reliance.

India’s new medical devices policy that aims to encourage domestic manufacturing of medical devices in the country is expected to support India’s aim of becoming a manufacturing hub, according to a report from GlobalData.

The Indian government has been making moves towards domestic manufacturing of medical devices as reliance on foreign imports caused shortages of medical supplies during the COVID-19 pandemic, the report stated.

GlobalData noted that the country’s new National Medical Devices Policy 2022, as well as other incentives offered by the government, will both reduce reliance on foreign imports and create employment opportunities.

“India’s manufacturing capabilities have seen significant development in the last few years, with GlobalData’s research revealing that India was among the top three medical devices markets in Asia-Pacific in 2021, and is expected to grow at a compound annual growth rate (CAGR) of 7.9% through to 2030,” said GlobalData’s practice head on the medical devices team, Rohit Anand.

READ MORE: Rise in Indian medicine exports may cause patent woes in Australia: Fitch

Anand noted that the state government of Uttar Pradesh has now initiated steps to encourage medical device manufacturers to begin production of high-end medical devices.

The state government has also recently announced a list of incentives, including subsidies on capital interest; incentives on air cargo, zero waste, and skill development; reimbursement of State Goods and Services Tax (SGST), and a patent filing fee. These will be given to companies setting up units in the state’s first Medical Devices Park.

The Uttar Pradesh government has also offered industrial plots under this scheme at a lower cost, GlobalData added.

“Whilst no specific areas have been announced as of yet, diagnostic Imaging devices could be a key area of interest, from the point of view of both the government and manufacturers,” Anand said, commenting on the state government’s initiatives.

Anand advised domestic and multinational companies to consider utilizing the Indian government’s move towards domestic manufacturing to gain market share.

“GlobalData expects that UP’s (Uttar Pradesh) incentives, and the increased availability of skilled local labour, will help the state become a preferred manufacturing destination in India,” he said.

Follow the link for more news on

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.